Mission
Our team is dedicated to providing exceptional clinical operations services to our clients, with the ultimate goal of advancing their investigational products from early phase clinical development through regulatory approval. We believe in the importance of patient diversity in clinical trials, access to the approved medications, and strive to make this a reality through our work.
About us
Hager Clinical Research is focused on collaborating with emerging biotechnology/pharmaceutical companies to provide various levels of clinical operations services and engagement depending on your goals and needs.
​
We are committed to providing leadership expertise to clinical operations teams within a strategic medical/clinical direction for all clinical operations activities. With a strong medical, clinical & scientific background and over 23 years in the field of clinical research (phase 1, 2, 3, 4), we utilize our expertise to support our clients in order to advance their investigational products from early phase clinical development through regulatory approval in different therapeutic areas, including but not limited to: Cardiovascular, cardiovascular surgery, dermatology, diabetes and metabolic disorders, gastroenterology, hematology, hematological oncology, immunology, infectious disease, nephrology, oncology, urology, respiratory, and vascular system.
​
We provide short or long-term consulting services, engaging in direct interactions with vendors, internal teams and investigational research centers (community based &/or academic institutions), from clinical project start-up through completion of study. We will manage all study related activities, including filling in gaps until resources are in place.